| 局部晚期食管癌根治性同步放化疗研究进展 |
| |
| 引用本文： | 王诗嘉,肖泽芬. 局部晚期食管癌根治性同步放化疗研究进展[J]. 中华放射肿瘤学杂志, 2022, 31(11): 1065-1069. DOI: 10.3760/cma.j.cn113030-20210427-00178 |
| |
| 作者姓名： | 王诗嘉 肖泽芬 |
| |
| 作者单位： | 国家癌症中心/国家肿瘤临床医学研究中心/中国医学科学院北京协和医学院肿瘤医院放疗科,北京 100021 |
| |
| 摘 要： | 目前不宜根治性手术治疗的局部晚期食管癌的标准治疗模式是根治性同步放化疗。放疗技术的进展、放疗剂量和放疗靶区范围的异同、同步化疗和免疫治疗等相关问题以及最新的研究成果是局部晚期食管癌治疗应关注的重点,本文对此进行综述,以期为临床治疗提供参考与帮助。
|
| 关 键 词： | 食管肿瘤 局部晚期 同步放化疗 免疫治疗 |
| 收稿时间： | 2021-04-27 |
Research progress on radical concurrent chemoradiotherapy for locally advanced esophageal cancer |
| |
| Wang Shijia,Xiao Zefen. Research progress on radical concurrent chemoradiotherapy for locally advanced esophageal cancer[J]. Chinese Journal of Radiation Oncology, 2022, 31(11): 1065-1069. DOI: 10.3760/cma.j.cn113030-20210427-00178 |
| |
| Authors: | Wang Shijia Xiao Zefen |
| |
| Affiliation: | Department of Radiation Oncology, National Cancer Center / National Clinical Research Center for Cancer / Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China |
| |
| Abstract: | The current standard treatment modality for unresectable locally advanced esophageal cancer is radical concurrent chemoradiotherapy. In this article, research progress on radiotherapy techniques, differences in radiotherapy dose and target volume, exploration in concurrent chemotherapy and immunotherapy was reviewed, aiming to provide reference and evidence for clinical treatment. |
| |
| Keywords: | Esophageal neoplasms Locally advanced Concurrent chemoradiotherapy Immunotherapy |
|
| 点击此处可从《中华放射肿瘤学杂志》浏览原始摘要信息 |
|
点击此处可从《中华放射肿瘤学杂志》下载全文 |
